Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients

Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients

Abstract Objective To investigate the clinical efficacy, incidence of radiation pneumonitis, and impact on lung function of sequential chemoradiotherapy (SCRT) and concurrent chemoradiotherapy (CCRT) in the treatment of lung cancer. Method From January 2020 to December 2022, 158 patients with non-sm...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jinbiao Xu, Qiao Ji, Jianxiong Deng, Feng Yu
Format:	Article
Language:	English
Published:	BMC 2025-05-01
Series:	BioMedical Engineering OnLine
Subjects:	Sequential chemoradiotherapy Concurrent chemoradiotherapy Lung cancer Clinical efficacy Pulmonary function
Online Access:	https://doi.org/10.1186/s12938-025-01390-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
by: Arunima Gupta, et al.
Published: (2014-01-01)

Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study
by: Zhou Meng-Xi, et al.
Published: (2025-01-01)

Quality of life in patients with pan-cancer undergoing concurrent chemoradiotherapy: a bibliometric analysis (1995-2024)
by: Ao Shen, et al.
Published: (2025-08-01)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
by: Mao‐Chih Hsieh, et al.
Published: (2018-06-01)

Immunotherapy concurrently administered with chemoradiotherapy in limited-stage small-cell lung cancer
by: Liuhua Long, et al.
Published: (2025-07-01)

Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy
by: Fiorella Di Pastena, et al.
Published: (2024-11-01)

Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non‐small cell lung cancer
by: Xiaxia Chen, et al.
Published: (2024-09-01)

Sequential therapy (triple drug-based induction chemotherapy followed by concurrent chemoradiotherapy) in locally advanced inoperable head and neck cancer patients - Single institute experience
by: Naresh Somani, et al.
Published: (2011-01-01)

Longitudinal dynamic MRI radiomic models for early prediction of prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy
by: Chang Cai, et al.
Published: (2024-12-01)

Consolidation immunotherapy following concurrent chemoradiotherapy in a patient with sinonasal NUT carcinoma: a case report
by: Xiaotao Geng, et al.
Published: (2024-12-01)

Development and validation of a prognostic nomogram incorporating neutrophil-to-albumin ratio for predicting overall survival in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy
by: Xin Hua, et al.
Published: (2025-01-01)

The clinical outcomes of induction chemotherapy followed by radiotherapy vs. chemoradiotherapy in locally advanced hypopharyngeal squamous cell carcinoma: A retrospective study
by: Ke Jiang, et al.
Published: (2024-10-01)

MRI radiomics and nutritional-inflammatory biomarkers: a powerful combination for predicting progression-free survival in cervical cancer patients undergoing concurrent chemoradiotherapy
by: Qi Yan, et al.
Published: (2024-10-01)

A Phase II Clinical Trial of Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced High-Grade Thymic Tumors
by: Ning Xu, MD, et al.
Published: (2025-06-01)

Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy for locally advanced cervical cancer: a multicenter real-world study
by: Jiwei Li, et al.
Published: (2025-05-01)

Comment on: Concurrent chemoradiotherapy versus radiotherapy alone in postoperative high-risk adenoid cystic carcinoma of the head and neck: A propensity score-matched analysis
by: Erkan Topkan, et al.
Published: (2025-07-01)

Tislelizumab and GP regimen neoadjuvant therapy followed by concurrent chemoradiotherapy with nimotuzumab in patients with stage IVA nasopharyngeal carcinoma: a retrospective study
by: Mingfen Lai, et al.
Published: (2025-06-01)

Concurrent chemoradiotherapy with S-1 versus platinum in the treatment of locoregionally advanced nasopharyngeal carcinoma: a multicenter, retrospective, propensity score-matched analysis
by: Chenbin Bian, et al.
Published: (2024-11-01)

Harnessing unsupervised machine learning with [18F]FDG PET/CT to develop a composite model for predicting overall survival in cervical cancer patients undergoing concurrent chemoradiotherapy
by: Jinyu Shi, et al.
Published: (2025-05-01)

Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial
by: Ke Zhang, et al.
Published: (2025-02-01)

Nomogram based on the advanced lung cancer inflammation index and other relevant clinical factors for patients with cervical squamous cell carcinoma undergoing concurrent chemoradiotherapy
by: Xiao-Chun Wang, et al.
Published: (2025-07-01)

Effect of concurrent chemoradiation with cisplatin versus concurrent chemoradiation with carboplatin in locally advanced carcinoma cervix: A quasi-experimental study
by: Syed Md. Asadul Hoque, et al.
Published: (2025-05-01)

Ten-year survival outcomes of concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in the IMRT era: A retrospective cohort study stratified by high- and low-risk profiles
by: Wang-Jian Li, et al.
Published: (2025-09-01)

Consolidation Chemotherapy Provided Survival Benefit for Esophageal Squamous Cell Carcinoma Patients Who Underwent Concurrent Chemoradiotherapy Lower Than 60 Gy
by: Hualei Zhang, et al.
Published: (2025-04-01)

S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study
by: Xin Wang, et al.
Published: (2024-12-01)

Evaluation of the efficacy of probiotics in the chemoradiotherapy of colorectal cancer: a meta-analysis of Randomized Controlled Trials
by: Rong Yang, et al.
Published: (2025-04-01)

Comparison of oncological outcomes and complication rate between radical hysterectomy and concurrent chemoradiotherapy in stage IIICr cervical cancer without parametrial invasion
by: Hee Yeun Yoon, et al.
Published: (2025-04-01)

A comparative analysis of survival outcomes and adverse effects between preoperative brachytherapy with radical surgery and concurrent chemoradiotherapy in patients with locally advanced cervical cancer
by: Yuna Niu, et al.
Published: (2025-02-01)

Assessment of various risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting amongst patients receiving concurrent chemoradiotherapy: A prospective study
by: S. Navaneetha Krishnan, et al.
Published: (2025-01-01)

Long‐Term Survival Analysis of Neoadjuvant Chemoradiotherapy Versus Adjuvant Chemoradiotherapy for Locally Advanced Low Rectal Cancer
by: Siyuan Chen, et al.
Published: (2025-08-01)

Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio
by: Jing Yu, et al.
Published: (2024-12-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01)

Efficacies of radiotherapy in rectal cancer patients treated with total mesorectal excision or other types of surgery: an updated meta-analysis
by: Wenshu Wang, et al.
Published: (2025-05-01)

Total proctocolectomy with end ileostomy for acute onset of ulcerative colitis during chemoradiotherapy for lung adenocarcinoma (successfully treated by surgery): a case report
by: Koichi Mohri, et al.
Published: (2020-06-01)

A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancer
by: Yosuke Miura, et al.
Published: (2025-08-01)

Single-cell RNA sequencing analysis reveals a lack of CXCL13+ T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy
by: Xia Li, et al.
Published: (2025-06-01)

Erythropoietins (Epostim®) during chemoradiotherapy for malignancies in anemic patients
by: V. A. Titova, et al.
Published: (2014-08-01)

Music-Assisted Progressive Muscle Relaxation in Patients with Locally Advanced Gastric Cancer Undergoing Concurrent Chemoradiotherapy
by: Juwei Zhong, et al.
Published: (2025-05-01)

Integrating pan-immune-inflammation value into personalized survival prediction of nasopharyngeal carcinoma: a large-scale long-term retrospective study
by: Wen-Chao Li, et al.
Published: (2025-07-01)

The effect of the relative dose intensity of chemoradiotherapy on the effectiveness of therapy of locally advanced unresectable non-small cell lung cancer
by: A. E. Glukhareva, et al.
Published: (2024-03-01)